Mar 21, 2023, 09:34 AM by

International strategic health and life science specialists Inizio have increased their organizational-wide focus on diversity, equity, and inclusion with the appointment of Stefanie Christmas as their new Global Head of Diversity, Equity & Inclusion (DE&I).

Mar 21, 2023, 01:00 AM by User Not Found

Bio-IT World | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies.

Mar 16, 2023, 09:42 AM by

It will provide strategies to de-risk each stage of the R&D pipeline, with particular focus on regulatory drivers, investigatory objectives, and practical concerns that are relevant to toxicologists.

Mar 16, 2023, 09:42 AM by

Arranta Bio, a Recipharm company and leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, has announced that it has doubled capacity at its Watertown, MA facility for process development services supporting RNA therapeutics.

Mar 16, 2023, 01:00 AM by User Not Found

Bio-IT World | Insufficient taxonomic information in public sequence records is a longstanding problem that was again brought to light in a recent study of simulated microbial communities. Researchers in Spain, using standard techniques to explore virtual microbiome communities, found that results obtained from DNA analyses bear little resemblance to the real-world bacterial populations being imitated and many of the detected species are not actually present.

Mar 15, 2023, 14:25 PM by

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and ProofPilot, the industry's first digital protocol automation platform for clinical trial, today announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot’s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Mar 15, 2023, 14:25 PM by

The COVID-19 pandemic has had a major impact on the implant industry, both positively and negatively. Here are some of the main effects:

Mar 15, 2023, 14:23 PM by

Darling Ingredients’ health brand Rousselot, the global leader1 in collagen-based solutions, announced today that a new study has found that utilization of highly purified gelatin biomaterials for 3D in vitro models can significantly enhance the reliability and reproducibility in these models, creating new possibilities for replacing preclinical animal trials.

Mar 15, 2023, 14:23 PM by

[London, UK] - Clinion, a leading provider of eClinical solutions, has announced the launch of its new AI-powered medical coding solution. This innovative solution is designed to transform the medical coding process for clinical trials, offering a faster, more efficient, and more accurate way to code medical data. Medical coding is a critical component of clinical trials, as it enables researchers to accurately capture and analyze medical data. However, the process of medical coding can be time-consuming, error-prone, and costly, often leading to delays in the clinical trial process. Clinion's new AI Medical Coding is set to revolutionize the clinical trial process by leveraging the power of artificial intelligence to automate medical coding. The solution uses advanced machine learning algorithms to analyze medical data and assign the appropriate medical codes, significantly reducing the time and effort required for manual coding. The solution also provides real-time feedback to clinical trial teams, allowing them to make data-driven decisions more quickly and efficiently. With improved accuracy and speed, Clinion's medical coding solution enables clinical trial teams to deliver high-quality results and insights faster than ever before. "We are thrilled to launch AI Medical Coding, which we believe will transform the clinical trial process," said Manuj Vangipurapu, CEO of Clinion. "By harnessing the power of AI, we can provide clinical trial teams with a faster, more efficient, and more accurate way to code medical data. This will enable our customers to make data-driven decisions more quickly and effectively, ultimately accelerating the drug development process and bringing new treatments to patients faster." Clinion's medical coding solution is the latest addition to its suite of eClinical solutions, which include EDC, RTSM, ePRO, eConsent and CTMS. sWith over 500+ clinical trials successfully conducted using its solutions, Clinion is the go-to partner for companies seeking to streamline their clinical trial process and bring new treatments to market faster. For more information on Clinion's new AI-powered medical coding solution, please visit clinion.com. About Clinion Clinion is a global clinical technology company that offers AI-enabled eClinical solutions consisting of EDC, RTSM, CTMS, eCOA and Document Automation that cover the entire clinical trial lifecycle. Clinion is committed to innovating the future of clinical trials through AI/ML and empowering its partners to manage trials more efficiently at lesser costs. For more information, please visit www.clinion.com.

Mar 15, 2023, 14:22 PM by

Discover the top 5 clinical trial technology trends in 2023. From wearables to AI, Digital Patient engagement tools and techniques that are shaping the future of clinical research

Mar 15, 2023, 14:21 PM by

Orbita, a provider of virtual assistants for healthcare, announced a partnership with Isabel Healthcare that will improve patients’ digital experiences, helping them find the right care for their individual health circumstances.

Mar 15, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers have found that dyskerin, a protein that provides stability to non-coding small nucleolar RNAs, signals when cutaneous squamous cell carcinomas are preparing to metastasize by migrating to the lymph nodes. Because these cancer cells temporarily stop consuming glucose and instead feed on low-density lipoprotein cholesterol molecules, the new marker may be a promising candidate for treatments involving lipid metabolism inhibitors.

Mar 14, 2023, 09:56 AM by

Confluence of Industries Requires Nimble, Creative, and Cross-functional Expertise that Flexes and Scales For Pure-play and Multi-line Businesses

Mar 14, 2023, 01:00 AM by User Not Found

Bio-IT World | Spatial biology is poised for an explosion in the next few years, said Colin Enderlein, a principle at DeciBio Consulting. Speaking in San Diego at the Molecular and Precision Med Tri-Con, Enderlein shared the results of DeciBio’s recent market report on the space.

Mar 13, 2023, 11:15 AM by

Mar 13, 2023, 11:13 AM by

Mar 13, 2023, 11:11 AM by

Mar 13, 2023, 11:09 AM by

NCC Group – one of the world’s largest and most respected security consultancies with over 35 global offices, 2,000 employees and 14,000 clients – today appointed Doug Klotnia as global capability leader for Managed Services.

Mar 9, 2023, 09:42 AM by

Automata, a leader in open, integrated laboratory automation, announces its expansion into the US. Automata is accelerating scientific and health outcomes by making automation a reality for every lab.

Mar 9, 2023, 09:40 AM by

Today, Thermo Fisher Scientific launched an easy-to-use solution for the analysis of trace elements in environmental, food, and pharmaceutical laboratories. The Thermo Scientific iCAP RQplus ICP-MS Analyzer provides the operational simplicity and stability that laboratories require for ongoing daily analysis of trace elements at low concentrations in a wide range of sample types. The company also announced the Thermo Scientific iSC-65 Autosampler which enhances the productivity of the Thermo Scientific iCAP Qnova Series ICP-MS analyzer and the Thermo Scientific iCAP PRO Series ICP-OES.